COVID-19 pandemic in Sikkim
Impact of the COVID-19 pandemic in Sikkim, India
The COVID-19 pandemic in Sikkim is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in the Indian state of Sikkim was reported on 23 May 2020.
Background[edit]

The World Health Organization (WHO) declared the outbreak of COVID-19 a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. The first case of COVID-19 in India was reported on 30 January 2020 in the state of Kerala.
Timeline[edit]
2020[edit]
On 23 May 2020, Sikkim reported its first COVID-19 case. The patient was a 25-year-old male who had returned from Delhi. Following this, the state government implemented strict measures to contain the spread of the virus, including lockdowns and travel restrictions.
2021[edit]
In 2021, Sikkim saw a rise in COVID-19 cases, mirroring the national trend. The state government ramped up testing and vaccination efforts. By mid-2021, Sikkim had vaccinated a significant portion of its population, focusing on frontline workers and vulnerable groups.
Government response[edit]
The government of Sikkim took several measures to control the spread of COVID-19. These included:
- Lockdowns and curfews: Sikkim imposed lockdowns and curfews to limit movement and gatherings.
- Testing and contact tracing: The state increased testing capacity and implemented contact tracing to identify and isolate cases.
- Healthcare infrastructure: Efforts were made to enhance healthcare facilities, including setting up COVID-19 care centers and increasing the number of hospital beds.
- Vaccination drive: Sikkim actively participated in the national vaccination drive, aiming to vaccinate all eligible citizens.
Impact[edit]
The pandemic had a significant impact on Sikkim's economy, particularly affecting the tourism sector, which is a major source of revenue for the state. Educational institutions were closed, and there was a shift to online learning.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian